Autologous mixed lymphocyte reaction in man. XX. The cellular and molecular basis of deficient T-T AMLR in aging humans. 1987

B Vayuvegula, and M Shimizu, and S Gupta

In the T-T AMLR, suppressor functions are generated, and because in human aging a deficiency of suppressor function has been observed, we examined the T-T AMLR in aging humans. Non-T cells were irradiated and used as stimulators against fresh autologous responder T cells to generate activated T cells (TA). TA cells were irradiated and used as stimulators against fresh autologous responder T cells (T-TA AMLR), CD4+ cells (CD4-TA AMLR), or CD8+ cells (CD8-TA AMLR) in the presence or absence of recombinant interleukin 2 (rIL-2). T cells from young and aging subjects were stimulated with phytohemagglutinin and examined for the expression of IL-2 receptors (IL-2R) and transferrin receptors. A significant decrease in T-TA, CD4-TA, and CD8-TA AMLR was observed in aging humans when compared with simultaneously studied sex-matched young controls. In vitro addition of rIL-2 resulted in an enhanced AMLR in both young and aging subjects; however, the total [3H]thymidine incorporation by T cells and T-cell subsets from aging in the presence of rIL-2 was lower than that of young subjects' T cells and T-cell subsets in the presence of rIL-2. The net increase (over the baseline values) in [3H]thymidine incorporation in T-TA and CD8-TA by rIL-2 was significantly less in the aging group when compared to the young group. In contrast, the rIL-2-induced net increase in [3H]thymidine incorporation in CD4-TA AMLR in both groups was comparable. T cells expressing IL-2R and transferrin receptors were of similar proportions in two groups. These data show a deficiency of the T-T AMLR in aging humans that appears to be, at least in part, due to deficient response to rIL-2. This deficiency of the T-T AMLR might be responsible for deficient suppressor activity, hyperimmunoglobulinemia, and the presence of autoantibodies in aging humans.

UI MeSH Term Description Entries
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007959 Lymphocyte Culture Test, Mixed Measure of histocompatibility at the HL-A locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way MLC test, the lymphocytes from one of the individuals are inactivated (usually by treatment with MITOMYCIN or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens. Leukocyte Culture Test, Mixed,Mixed Lymphocyte Culture Test,Mixed Lymphocyte Reaction,Mixed Leukocyte Culture Test,Mixed Leukocyte Reaction,Leukocyte Reaction, Mixed,Leukocyte Reactions, Mixed,Lymphocyte Reaction, Mixed,Lymphocyte Reactions, Mixed,Mixed Leukocyte Reactions,Mixed Lymphocyte Reactions
D008297 Male Males
D011990 Receptors, Transferrin Membrane glycoproteins found in high concentrations on iron-utilizing cells. They specifically bind iron-bearing transferrin, are endocytosed with its ligand and then returned to the cell surface where transferrin without its iron is released. Transferrin Receptors,Transferrin Receptor,Receptor, Transferrin
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

B Vayuvegula, and M Shimizu, and S Gupta
June 1984, Journal of clinical & laboratory immunology,
B Vayuvegula, and M Shimizu, and S Gupta
March 1984, Scandinavian journal of immunology,
B Vayuvegula, and M Shimizu, and S Gupta
May 1985, Journal of clinical immunology,
B Vayuvegula, and M Shimizu, and S Gupta
January 1990, Nihon Gan Chiryo Gakkai shi,
B Vayuvegula, and M Shimizu, and S Gupta
April 1992, International journal of cancer,
B Vayuvegula, and M Shimizu, and S Gupta
May 1983, Behring Institute Mitteilungen,
B Vayuvegula, and M Shimizu, and S Gupta
January 1988, Archivum immunologiae et therapiae experimentalis,
B Vayuvegula, and M Shimizu, and S Gupta
November 1989, Clinical and experimental immunology,
Copied contents to your clipboard!